Compared to modern GHRH/secretagogue combination therapies like CJC-1295/Ipamorelin, Sermorelin is the older, single-pathway, shorter-half-life option
Peptide stability and degradation analysis
Han T, Wu Y, Han W, Yan K, Zhao J, Sun Y
Quick Reference: Standard Protocol Community-documented protocol: 250 mcg subcutaneous in the morning, 3 days per week, for 8-week cycles -- far below the 2.4 mg weekly clinical trial dose, reflecting conservative research-peptide practice
10.1371/journal.pgen.1004815 PLoS Genet
While FITAMINAT strives to ensure the accuracy of its product images and information, some manufacturing changes to packaging may be pending updates on our site